BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
258 hedge funds and large institutions have $6.02B invested in Blueprint Medicines in 2023 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 67 increasing their positions, 97 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
258
Holders Change
+39
Holders Change %
+17.81%
% of All Funds
3.78%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
60
Increased
67
Reduced
97
Closed
17
Calls
$131M
Puts
$102M
Net Calls
+$29M
Net Calls Change
+$56.1M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$215M |
| 2 |
2
Lord, Abbett & Co
Jersey City,
New Jersey
|
$134M |
| 3 |
3
Pictet Asset Management
Carouge,
Switzerland
|
$162M |
| 4 |
4
Man Group
London,
United Kingdom
|
$34.9M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$38.5M |
